Your search returned 8 results.

Results
	1.	Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. [electronic resource] by Armstrong, Edward P Skrepnek, Grant H Haim Erder, M Producer: 20070315 In: Current medical research and opinion vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. [electronic resource] by Ventura, Daniel Armstrong, Edward P Skrepnek, Grant H Haim Erder, M Producer: 20070315 In: Current medical research and opinion vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study. [electronic resource] by Rivera, Edgardo Haim Erder, M Fridman, Moshe Frye, Debra Hortobagyi, Gabriel N Producer: 20031003 In: Breast cancer research : BCR vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons. [electronic resource] by Wu, Eric Q Ben-Hamadi, Rym Yu, Andrew P Tang, Jackson Haim Erder, M Bose, Anjana Producer: 20110425 In: Journal of medical economics vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents. [electronic resource] by Sikirica, Vanja Haim Erder, M Xie, Jipan Macaulay, Dendy Diener, Melissa Hodgkins, Paul Wu, Eric Q Producer: 20121210 In: PharmacoEconomics vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study. [electronic resource] by Yu, Andrew P Xie, Jipan Bensimon, Arielle Parikh, Kejal Wu, Eric Q Ben-Hamadi, Rym Blum, Steven Haim Erder, M Producer: 20110503 In: Journal of medical economics vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Examining the heterogeneity of treatment patterns in attention deficit hyperactivity disorder among children and adolescents in the Texas Medicaid population: modeling suboptimal treatment response. [electronic resource] by Grebla, Regina Setyawan, Juliana Park, Chanhyun Richards, Kristin M Nwokeji, Esmond D Pawaskar, Manjiri Haim Erder, M Lawson, Kenneth A Producer: 20200129 In: Journal of medical economics vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Impact of mental health comorbidities on health care utilization and expenditure in a large US managed care adult population with ADHD. [electronic resource] by Kawatkar, Aniket A Knight, Tara K Moss, Robert A Sikirica, Vanja Chu, Li-Hao Hodgkins, Paul Haim Erder, M Nichol, Michael B Producer: 20141121 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)